Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in World Allergy Organization Journal, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 27,003 followers.

Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children... https://t.co/i9DRyosZYe

Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a… http://t.co/VPbJiqfp7U

Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a… http://t.co/xKdigNPQib

WAO Journal: Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children.http://t.co/mfwtkNYQhW

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.